2024
Leukocytospermia does not negatively impact outcomes in in vitro fertilization cycles with intracytoplasmic sperm injection and preimplantation genetic testing for aneuploidy: findings from 5435 cycles
Gill P, Puchalt N, Molinaro T, Werner M, Seli E, Hotaling J, Cheng P. Leukocytospermia does not negatively impact outcomes in in vitro fertilization cycles with intracytoplasmic sperm injection and preimplantation genetic testing for aneuploidy: findings from 5435 cycles. Journal Of Assisted Reproduction And Genetics 2024, 41: 1213-1219. PMID: 38642270, PMCID: PMC11143111, DOI: 10.1007/s10815-024-03085-x.Peer-Reviewed Original ResearchConceptsLive birth rateIntracytoplasmic sperm injectionClinical pregnancy rateSustained implantation ratesIn vitro fertilizationIn vitro fertilization cyclesPreimplantation genetic testingBlastulation ratePGT-AAneuploidy rateEmbryological outcomesSperm injectionGenetic testingEuploid embryo transferPrevalence of leukocytospermiaRetrospective cohort studyMale partner ageImplantation rateBaseline characteristicsEmbryo transferLeukocytospermiaFertilization cyclesCohort studyPregnancy ratePrimary outcome
2022
Follicular activation in women previously diagnosed with poor ovarian response: a randomized, controlled trial
Díaz-García C, Herraiz S, Pamplona L, Subirá J, Soriano MJ, Simon C, Seli E, Pellicer A. Follicular activation in women previously diagnosed with poor ovarian response: a randomized, controlled trial. Fertility And Sterility 2022, 117: 747-755. PMID: 35367015, DOI: 10.1016/j.fertnstert.2021.12.034.Peer-Reviewed Original ResearchConceptsPoor ovarian responseAntral follicle countOvarian reserve markersLive birth rateOvarian fragmentationFollicular activationFollicle countOvarian responseReserve markersHormone levelsPregnancy rateReproductive outcomesEmbryo transferTotal antral follicle countMII oocytesSerum antimüllerian hormoneAntimüllerian hormone levelsBirth rateMetaphase II oocytesEmbryology (ESHRE) criteriaHippo pathway inhibitionAntimüllerian hormoneSecondary outcomesFertilization cyclesIVF outcomesOvarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP)
Cakiroglu Y, Yuceturk A, Karaosmanoglu O, Kopuk SY, Korun ZEU, Herlihy N, Scott RT, Tiras B, Seli E. Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP). Aging 2022, 14: 2513-2523. PMID: 35320118, PMCID: PMC9004561, DOI: 10.18632/aging.203972.Peer-Reviewed Original ResearchConceptsPoor ovarian responseOvarian reserve parametersPlatelet-rich plasmaAutologous platelet-rich plasmaReserve parametersIntraovarian injectionIVF outcomesOvarian responsePRP treatmentProspective randomized clinical trialsRich plasmaHigher serum AMHLower serum FSHUnderwent embryo transferReproductive-age womenRandomized clinical trialsWide clinical applicationPOSEIDON criteriaSerum AMHSerum FSHPRP injectionClinical efficacyAge womenClinical trialsPregnancy rate
2021
Analysis of female demographics in the United States: life expectancy, education, employment, family building decisions, and fertility service utilization
Esencan E, Simsek B, Seli E. Analysis of female demographics in the United States: life expectancy, education, employment, family building decisions, and fertility service utilization. Current Opinion In Obstetrics & Gynecology 2021, 33: 170-177. PMID: 33797423, DOI: 10.1097/gco.0000000000000704.Peer-Reviewed Original ResearchConceptsReproductive technology treatmentMedian agePregnancy attemptsART cyclesMean ageService utilizationPregnancy rateFemale fertility ratesFamily-building decisionsFertility servicesFraction of womenTechnology treatmentDonor eggsFertility rateFirst birthWomenLife expectancyAgeFemale demographicDiagnosisMarried women
2014
Metabolomic Assessment of Embryo Viability
Uyar A, Seli E. Metabolomic Assessment of Embryo Viability. Seminars In Reproductive Medicine 2014, 32: 141-152. PMID: 24515909, PMCID: PMC4109799, DOI: 10.1055/s-0033-1363556.Peer-Reviewed Original ResearchConceptsSingle embryo transferClinical pregnancyInitial promising resultsPreimplantation embryo metabolismPregnancy rateEmbryo selection processEmbryo viabilityEmbryo transferImplantation potentialSignificant associationConsistent benefitElimination of factorsConsecutive studiesClinical IVF laboratoryMetabolomic assessmentSuccess rateIVF laboratoryCulture mediumInconsistent findingsEmbryo metabolismMetabolomics studiesMetabolomics technologyDevelopmental potentialPrincipal studiesMedia metabolites
2012
The association between fertility clinic performance and cycle volume: implications for public reporting of provider performance data
Gong D, Seli E. The association between fertility clinic performance and cycle volume: implications for public reporting of provider performance data. Fertility And Sterility 2012, 98: 55-62.e1. PMID: 22521157, DOI: 10.1016/j.fertnstert.2012.03.036.Peer-Reviewed Original ResearchConceptsLive birth rateProvider performance dataClinic performanceSuccess rateCycle volumeReproductive technology clinicsRetrospective longitudinal analysisHealth care providersBirth ratePublic reportingART cyclesPregnancy rateART treatmentStudy populationMAIN OUTCOMECare providersStratification analysisTechnology clinicsPatient behaviorClinicDisease controlPublic quality reportingPatientsProvider performanceLongitudinal analysis
2010
Perspectives on emerging biomarkers for non-invasive assessment of embryo viability in assisted reproduction.
Aydiner F, Yetkin CE, Seli E. Perspectives on emerging biomarkers for non-invasive assessment of embryo viability in assisted reproduction. 2010, 10: 206-15. PMID: 20196727, DOI: 10.2174/156652410790963349.Peer-Reviewed Original Research
2008
Assessment of embryo viability in assisted reproductive technology: shortcomings of current approaches and the emerging role of metabolomics
Bromer JG, Seli E. Assessment of embryo viability in assisted reproductive technology: shortcomings of current approaches and the emerging role of metabolomics. Current Opinion In Obstetrics & Gynecology 2008, 20: 234-241. PMID: 18460937, DOI: 10.1097/gco.0b013e3282fe723d.Peer-Reviewed Original ResearchConceptsHigher multiple pregnancy rateEmbryo assessmentMultiple pregnancy rateReproductive technology cyclesLower implantation rateReproductive technologiesAssessment of glucoseCleavage rateImplantation rateUse of metabolomicsPregnancy rateRole of metabolomicsEmbryo culture mediumEmbryo viabilityUseful adjunctGood embryosAmino acid metabolismReproductive medicineMetabolomic profilingTechnology cyclesAcid metabolismOxygen consumptionOverview of studiesEmbryo metabolismProteomic profiling
2005
Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window
Seli E, Kayisli UA, Cakmak H, Bukulmez O, Bildirici I, Guzeloglu-Kayisli O, Arici A. Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window. Human Reproduction 2005, 20: 3012-3017. PMID: 16024536, DOI: 10.1093/humrep/dei188.Peer-Reviewed Original ResearchConceptsLeukemia inhibitory factorInfertile womenLIF expressionFertile controlsExpression of LIFLeukemia inhibitory factor expressionAdverse effectsEndometrial LIF expressionPresence of hydrosalpingesWindow of implantationIVF-embryo transferGlandular epithelial cellsWestern blot findingsLIF immunoreactivityLIF levelsEndometrial receptivityEndometrial expressionImplantation windowPregnancy rateHydrosalpingesSalpingectomyImmunohistochemical analysisLow implantationInhibitory factorFactor expression
2004
Extent of nuclear DNA damage in ejaculated spermatozoa impacts on blastocyst development after in vitro fertilization
Seli E, Gardner DK, Schoolcraft WB, Moffatt O, Sakkas D. Extent of nuclear DNA damage in ejaculated spermatozoa impacts on blastocyst development after in vitro fertilization. Fertility And Sterility 2004, 82: 378-383. PMID: 15302287, DOI: 10.1016/j.fertnstert.2003.12.039.Peer-Reviewed Original ResearchConceptsBlastocyst developmentInfertility treatmentPregnancy rateTUNEL positivityIVF clinicsDNA strand breaksPrivate IVF clinicClinical pregnancy rateProspective comparative studyNick end labeling techniqueBlastocyst development ratePregnancy outcomesVs. 44MAIN OUTCOMESperm samplesLarge seriesSignificant negative correlationStrand breaksFlow cytometryTUNEL reactivityEnd-labeling techniqueIVFApoptotic cell deathPositivityNuclear DNA fragmentation